[Sentinel lymph node identification with methylene blue in cervical cancer]. (2004)

Peer-Reviewed Study · Yuan SH, Liang LZ, Liu JH, Zhang HZ, Xiong Y, Yan XJ, Wei M, Zhang CQ · September 2004

Yuan SH et al., 2004-09: Chinese series of 41 cervical cancer patients in which 2-4 mL of methylene blue injected around the tumour identified sentinel nodes in 75.6%, with nodes most often in the obturator fossa.

SLNs were detected in 31 of 41(75.6%) patients with cervical cancer of stage Ib1-IIb.

1089-92

Yuan SH et al., 2004-09: Chinese series of 41 cervical cancer patients in which 2-4 mL of methylene blue injected around the tumour identified sentinel nodes in 75.6%, with nodes most often in the obturator fossa. C2 China. Study type: prospective diagnostic series, N=41 (stage Ib1-IIb). Dose/route: 2-4 mL methylene blue injected at 4-6 sites around the tumour, 90-400 minutes before operation. Comparator: histology of the full node dissection (HE step sections plus immunohistochemistry). Funder/conflicts: none declared. Journal Ai Zheng (Chinese Journal of Cancer) 23(9):1089-92. Identification rate 75.6% is the paper's own figure. Study type: uncontrolled series.